Management of obstructive sleep apnea in Europe

COST Action B26 Grp; I. Fietze; T. Penzel; A. Alonderis; F. Barbe; M. R. Bonsignore; P. Calverly; W. De Backer; K. Diefenbach; V. Donic; M. M. Eijsvogel; K. A. Franklin; T. Gislason; L. Grote; J. Hedner; P. Jennum; L. Lavie; P. Lavie; P. Levy; C. Lombardi; W. Mallin; O. Marrone; J. M. Montserrat; E. S. Papathanasiou; G. Parati; R. Plywaczewski; M. Pretl; R. L. Riha; D. Rodenstein; T. Saaresranta; R. Schulz; P. Sliwinski; P. Steiropoulos; J. Svaza; Z. Tomori; P. Tonnesen; G. Varoneckas; J. Verbraecken; J. Vesely; A. Vitols; J. Zielinski; W. T. McNicholas

doi:10.1016/j.sleep.2010.10.003

Management of obstructive sleep apnea in Europe

COST Action B26 Grp, I. Fietze^*, T. Penzel, A. Alonderis, F. Barbe, M. R. Bonsignore, P. Calverly, W. De Backer, K. Diefenbach, V. Donic, M. M. Eijsvogel, K. A. Franklin, T. Gislason, L. Grote, J. Hedner, P. Jennum, L. Lavie, P. Lavie, P. Levy, C. LombardiW. Mallin, O. Marrone, J. M. Montserrat, E. S. Papathanasiou, G. Parati, R. Plywaczewski, M. Pretl, R. L. Riha, D. Rodenstein, T. Saaresranta, R. Schulz, P. Sliwinski, P. Steiropoulos, J. Svaza, Z. Tomori, P. Tonnesen, G. Varoneckas, J. Verbraecken, J. Vesely, A. Vitols, J. Zielinski, W. T. McNicholas

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services.

Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example.

Results: Sleep centers from 21 countries (38 physicians) participated. A broad consistency among countries with respect to the following was found: pathways included referral to sleep physicians/sleep laboratories, necessity for objective diagnosis (primarily by polysomnography), use of polygraphic methods, analysis of polysomnography (PSG), indications for positive airway pressure (PAP) therapy, application of standard continuous PAP (CPAP) therapy (100% with an CPAP/APAP ratio of 2.24:1), and the need (90.5%) and management of follow-up. Differences were apparent in reimbursement of the diagnostic procedures and follow-up, in the procedures for PAP titration from home APAP titration with portable sleep apnea monitoring (38.1%) up to hospital monitoring with PSG and APAP (85.7%), and in the qualification requirements of sleep physicians.

Conclusions: Management of OSA in different European countries is similar except for reimbursement rules, qualification of sleep specialists and procedures for titration of the CPAP treatment. A European network (such as the one accomplished by the European Cooperation in Science and Technology [COST] B26 Action) could be helpful for implementing these findings into health-service research in order to standardize management in a cost effective perspective. (C) 2010 Elsevier B.V. All rights reserved.

Original language	English
Pages (from-to)	190-197
Number of pages	8
Journal	Sleep medicine
Volume	12
Issue number	2
DOIs	https://doi.org/10.1016/j.sleep.2010.10.003
Publication status	Published - Feb 2011

Keywords / Materials (for Non-textual outputs)

Public health services
Sleep apnea
Sleep disordered breathing
OSA management
OSA therapy
OSA reimbursement
OSA treatment
AIRWAY PRESSURE DEVICES
PRACTICE PARAMETERS
APNOEA/HYPOPNOEA SYNDROME
CARDIOVASCULAR-DISEASE
ADULT PATIENTS
HEART HEALTH
DIAGNOSIS
CENTERS
POLYSOMNOGRAPHY
GUIDELINES

Access to Document

10.1016/j.sleep.2010.10.003

Cite this

COST Action B26 Grp, Fietze, I., Penzel, T., Alonderis, A., Barbe, F., Bonsignore, M. R., Calverly, P., De Backer, W., Diefenbach, K., Donic, V., Eijsvogel, M. M., Franklin, K. A., Gislason, T., Grote, L., Hedner, J., Jennum, P., Lavie, L., Lavie, P., Levy, P., ... McNicholas, W. T. (2011). Management of obstructive sleep apnea in Europe. Sleep medicine, 12(2), 190-197. https://doi.org/10.1016/j.sleep.2010.10.003

@article{cb36ccbb7f564a70a360c30997312267,

title = "Management of obstructive sleep apnea in Europe",

abstract = "Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services.Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example.Results: Sleep centers from 21 countries (38 physicians) participated. A broad consistency among countries with respect to the following was found: pathways included referral to sleep physicians/sleep laboratories, necessity for objective diagnosis (primarily by polysomnography), use of polygraphic methods, analysis of polysomnography (PSG), indications for positive airway pressure (PAP) therapy, application of standard continuous PAP (CPAP) therapy (100% with an CPAP/APAP ratio of 2.24:1), and the need (90.5%) and management of follow-up. Differences were apparent in reimbursement of the diagnostic procedures and follow-up, in the procedures for PAP titration from home APAP titration with portable sleep apnea monitoring (38.1%) up to hospital monitoring with PSG and APAP (85.7%), and in the qualification requirements of sleep physicians.Conclusions: Management of OSA in different European countries is similar except for reimbursement rules, qualification of sleep specialists and procedures for titration of the CPAP treatment. A European network (such as the one accomplished by the European Cooperation in Science and Technology [COST] B26 Action) could be helpful for implementing these findings into health-service research in order to standardize management in a cost effective perspective. (C) 2010 Elsevier B.V. All rights reserved.",

keywords = "Public health services, Sleep apnea, Sleep disordered breathing, OSA management, OSA therapy, OSA reimbursement, OSA treatment, AIRWAY PRESSURE DEVICES, PRACTICE PARAMETERS, APNOEA/HYPOPNOEA SYNDROME, CARDIOVASCULAR-DISEASE, ADULT PATIENTS, HEART HEALTH, DIAGNOSIS, CENTERS, POLYSOMNOGRAPHY, GUIDELINES",

author = "{COST Action B26 Grp} and I. Fietze and T. Penzel and A. Alonderis and F. Barbe and Bonsignore, {M. R.} and P. Calverly and {De Backer}, W. and K. Diefenbach and V. Donic and Eijsvogel, {M. M.} and Franklin, {K. A.} and T. Gislason and L. Grote and J. Hedner and P. Jennum and L. Lavie and P. Lavie and P. Levy and C. Lombardi and W. Mallin and O. Marrone and Montserrat, {J. M.} and Papathanasiou, {E. S.} and G. Parati and R. Plywaczewski and M. Pretl and Riha, {R. L.} and D. Rodenstein and T. Saaresranta and R. Schulz and P. Sliwinski and P. Steiropoulos and J. Svaza and Z. Tomori and P. Tonnesen and G. Varoneckas and J. Verbraecken and J. Vesely and A. Vitols and J. Zielinski and McNicholas, {W. T.}",

year = "2011",

month = feb,

doi = "10.1016/j.sleep.2010.10.003",

language = "English",

volume = "12",

pages = "190--197",

journal = "Sleep medicine",

issn = "1389-9457",

publisher = "Elsevier",

number = "2",

}

COST Action B26 Grp, Fietze, I, Penzel, T, Alonderis, A, Barbe, F, Bonsignore, MR, Calverly, P, De Backer, W, Diefenbach, K, Donic, V, Eijsvogel, MM, Franklin, KA, Gislason, T, Grote, L, Hedner, J, Jennum, P, Lavie, L, Lavie, P, Levy, P, Lombardi, C, Mallin, W, Marrone, O, Montserrat, JM, Papathanasiou, ES, Parati, G, Plywaczewski, R, Pretl, M, Riha, RL, Rodenstein, D, Saaresranta, T, Schulz, R, Sliwinski, P, Steiropoulos, P, Svaza, J, Tomori, Z, Tonnesen, P, Varoneckas, G, Verbraecken, J, Vesely, J, Vitols, A, Zielinski, J & McNicholas, WT 2011, 'Management of obstructive sleep apnea in Europe', Sleep medicine, vol. 12, no. 2, pp. 190-197. https://doi.org/10.1016/j.sleep.2010.10.003

TY - JOUR

T1 - Management of obstructive sleep apnea in Europe

AU - COST Action B26 Grp

AU - Fietze, I.

AU - Penzel, T.

AU - Alonderis, A.

AU - Barbe, F.

AU - Bonsignore, M. R.

AU - Calverly, P.

AU - De Backer, W.

AU - Diefenbach, K.

AU - Donic, V.

AU - Eijsvogel, M. M.

AU - Franklin, K. A.

AU - Gislason, T.

AU - Grote, L.

AU - Hedner, J.

AU - Jennum, P.

AU - Lavie, L.

AU - Lavie, P.

AU - Levy, P.

AU - Lombardi, C.

AU - Mallin, W.

AU - Marrone, O.

AU - Montserrat, J. M.

AU - Papathanasiou, E. S.

AU - Parati, G.

AU - Plywaczewski, R.

AU - Pretl, M.

AU - Riha, R. L.

AU - Rodenstein, D.

AU - Saaresranta, T.

AU - Schulz, R.

AU - Sliwinski, P.

AU - Steiropoulos, P.

AU - Svaza, J.

AU - Tomori, Z.

AU - Tonnesen, P.

AU - Varoneckas, G.

AU - Verbraecken, J.

AU - Vesely, J.

AU - Vitols, A.

AU - Zielinski, J.

AU - McNicholas, W. T.

PY - 2011/2

Y1 - 2011/2

N2 - Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services.Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example.Results: Sleep centers from 21 countries (38 physicians) participated. A broad consistency among countries with respect to the following was found: pathways included referral to sleep physicians/sleep laboratories, necessity for objective diagnosis (primarily by polysomnography), use of polygraphic methods, analysis of polysomnography (PSG), indications for positive airway pressure (PAP) therapy, application of standard continuous PAP (CPAP) therapy (100% with an CPAP/APAP ratio of 2.24:1), and the need (90.5%) and management of follow-up. Differences were apparent in reimbursement of the diagnostic procedures and follow-up, in the procedures for PAP titration from home APAP titration with portable sleep apnea monitoring (38.1%) up to hospital monitoring with PSG and APAP (85.7%), and in the qualification requirements of sleep physicians.Conclusions: Management of OSA in different European countries is similar except for reimbursement rules, qualification of sleep specialists and procedures for titration of the CPAP treatment. A European network (such as the one accomplished by the European Cooperation in Science and Technology [COST] B26 Action) could be helpful for implementing these findings into health-service research in order to standardize management in a cost effective perspective. (C) 2010 Elsevier B.V. All rights reserved.

AB - Objectives: In Europe, the services provided for the investigation and management of obstructive sleep apnoea (OSA) varies from country to country. The aim of this questionnaire-based study was to investigate the current status of diagnostic pathways and therapeutic approaches applied in the treatment of OSA in Europe, qualification requirements of physicians involved in diagnosis and treatment of OSA, and reimbursement of these services.Methods: Two questionnaires were sent to 39 physicians in 22 countries in Europe. In order to standardize the responses, the questionnaire was accompanied by an example.Results: Sleep centers from 21 countries (38 physicians) participated. A broad consistency among countries with respect to the following was found: pathways included referral to sleep physicians/sleep laboratories, necessity for objective diagnosis (primarily by polysomnography), use of polygraphic methods, analysis of polysomnography (PSG), indications for positive airway pressure (PAP) therapy, application of standard continuous PAP (CPAP) therapy (100% with an CPAP/APAP ratio of 2.24:1), and the need (90.5%) and management of follow-up. Differences were apparent in reimbursement of the diagnostic procedures and follow-up, in the procedures for PAP titration from home APAP titration with portable sleep apnea monitoring (38.1%) up to hospital monitoring with PSG and APAP (85.7%), and in the qualification requirements of sleep physicians.Conclusions: Management of OSA in different European countries is similar except for reimbursement rules, qualification of sleep specialists and procedures for titration of the CPAP treatment. A European network (such as the one accomplished by the European Cooperation in Science and Technology [COST] B26 Action) could be helpful for implementing these findings into health-service research in order to standardize management in a cost effective perspective. (C) 2010 Elsevier B.V. All rights reserved.

KW - Public health services

KW - Sleep apnea

KW - Sleep disordered breathing

KW - OSA management

KW - OSA therapy

KW - OSA reimbursement

KW - OSA treatment

KW - AIRWAY PRESSURE DEVICES

KW - PRACTICE PARAMETERS

KW - APNOEA/HYPOPNOEA SYNDROME

KW - CARDIOVASCULAR-DISEASE

KW - ADULT PATIENTS

KW - HEART HEALTH

KW - DIAGNOSIS

KW - CENTERS

KW - POLYSOMNOGRAPHY

KW - GUIDELINES

U2 - 10.1016/j.sleep.2010.10.003

DO - 10.1016/j.sleep.2010.10.003

M3 - Article

SN - 1389-9457

VL - 12

SP - 190

EP - 197

JO - Sleep medicine

JF - Sleep medicine

IS - 2

ER -

Management of obstructive sleep apnea in Europe

Abstract / Description of output

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this